Brief: Lisata Therapeutics Inc Reports Quarterly Loss Per Share Of $0.76
30/03/2023 21:37
March 30 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* LISATA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.76
Source text for Eikon: ID:nGNXbS4Q7J
Further company coverage: LSTA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco